Barclays raised the firm’s price target on Corebridge (CRBG) to $36 from $34 and keeps an Equal Weight rating on the shares. The company’s operating earnings comes in ahead of estimates on strong performance from Life Insurance and solid results in all other segments, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRBG:
Questions or Comments about the article? Write to editor@tipranks.com